Literature DB >> 31603681

Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli.

Michael Chan1, Fitzgerald S Lao1, Paul J Chu1, Jonathan Shpigelman1, Shiyin Yao1, Jason Nan1, Fumi Sato-Kaneko1, Vicky Li1, Tomoko Hayashi1, Maripat Corr2, Dennis A Carson1, Howard B Cottam1, Nikunj M Shukla1.   

Abstract

Agents that safely induce, enhance, or sustain multiple innate immune signaling pathways could be developed as potent vaccine adjuvants or coadjuvants. Using high-throughput screens with cell-based nuclear factor κB (NF-κB) and interferon stimulating response element (ISRE) reporter assays, we identified a bis-aryl sulfonamide bearing compound 1 that demonstrated sustained NF-κB and ISRE activation after a primary stimulus with lipopolysaccharide or interferon-α, respectively. Here, we present systematic structure-activity relationship (SAR) studies on the two phenyl rings and amide nitrogen of the sulfonamide group of compound 1 focused toward identification of affinity probes. The murine vaccination studies showed that compounds 1 and 33 when used as coadjuvants with monophosphoryl lipid A (MPLA) showed significant enhancement in antigen ovalbumin-specific immunoglobulin responses compared to MPLA alone. SAR studies pointed to the sites on the scaffold that can tolerate the introduction of aryl azide, biotin, and fluorescent rhodamine substituents to obtain several affinity and photoaffinity probes which will be utilized in concert for future target identification and mechanism of action studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31603681      PMCID: PMC8992017          DOI: 10.1021/acs.jmedchem.9b00870

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  57 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

Review 2.  Adjuvants for human vaccines.

Authors:  Carl R Alving; Kristina K Peachman; Mangala Rao; Steven G Reed
Journal:  Curr Opin Immunol       Date:  2012-04-19       Impact factor: 7.486

Review 3.  Combination adjuvants: the next generation of adjuvants?

Authors:  George Mutwiri; Volker Gerdts; Sylvia van Drunen Littel-van den Hurk; Gael Auray; Nelson Eng; Srinivas Garlapati; Lorne A Babiuk; Andrew Potter
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

4.  Prostaglandin photoaffinity probes: synthesis and biological activity of azide-substituted 16-phenoxy- and 17-phenyl-PGF2 alpha prostaglandins.

Authors:  K Kawada; E K Dolence; H Morita; T Kometani; D S Watt; A Balapure; T A Fitz; D J Orlicky; L E Gerschenson
Journal:  J Med Chem       Date:  1989-01       Impact factor: 7.446

5.  Synthesis, Characterization and Immunological Evaluation of Self-Adjuvanting Group A Streptococcal Vaccine Candidates Bearing Various Lipidic Adjuvanting Moieties.

Authors:  Vincent Fagan; Waleed M Hussein; Mei Su; Ashwini K Giddam; Michael R Batzloff; Michael F Good; Istvan Toth; Pavla Simerska
Journal:  Chembiochem       Date:  2017-02-15       Impact factor: 3.164

6.  Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4-6-year-old Girls: Results to Month 12 From a Randomized Trial.

Authors:  Lan Lin; Mercedes Macias Parra; Victor Y Sierra; Albino Salas Cespedes; Maria Angelica Granados; Adriana Luque; Silvia Damaso; Maria Mercedes Castrejon Alba; Luis Romano-Mazzotti; Frank Struyf
Journal:  Pediatr Infect Dis J       Date:  2018-04       Impact factor: 2.129

7.  IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.

Authors:  Meghan E Turnis; Xiao-Tong Song; Adham Bear; Aaron E Foster; Stephen Gottschalk; Malcolm K Brenner; Si-Yi Chen; Cliona M Rooney
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

8.  Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Authors:  Tomer Cooks; Ioannis S Pateras; Ohad Tarcic; Hilla Solomon; Aaron J Schetter; Sylvia Wilder; Guillermina Lozano; Eli Pikarsky; Tim Forshew; Nitzan Rosenfeld; Nitzan Rozenfeld; Noam Harpaz; Steven Itzkowitz; Curtis C Harris; Varda Rotter; Vassilis G Gorgoulis; Moshe Oren
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

Review 9.  Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients.

Authors:  Jiri Beran
Journal:  Expert Opin Biol Ther       Date:  2008-02       Impact factor: 4.388

10.  Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study.

Authors:  T Schwarz; M Spaczynski; A Kaufmann; J Wysocki; A Gałaj; K Schulze; P Suryakiran; F Thomas; D Descamps
Journal:  BJOG       Date:  2014-09-11       Impact factor: 6.531

View more
  4 in total

1.  Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release.

Authors:  Jonathan Shpigelman; Fitzgerald S Lao; Shiyin Yao; Chenyang Li; Tetsuya Saito; Fumi Sato-Kaneko; John P Nolan; Nikunj M Shukla; Minya Pu; Karen Messer; Howard B Cottam; Dennis A Carson; Maripat Corr; Tomoko Hayashi
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

2.  Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues.

Authors:  Rostom Ahmed-Belkacem; Marcel Hausdorff; Adrien Delpal; Priscila Sutto-Ortiz; Agathe M G Colmant; Franck Touret; Natacha S Ogando; Eric J Snijder; Bruno Canard; Bruno Coutard; Jean-Jacques Vasseur; Etienne Decroly; Françoise Debart
Journal:  J Med Chem       Date:  2022-04-19       Impact factor: 8.039

3.  Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.

Authors:  Fumi Sato-Kaneko; Shiyin Yao; Fitzgerald S Lao; Jason Nan; Jonathan Shpigelman; Annette Cheng; Tetsuya Saito; Karen Messer; Minya Pu; Nikunj M Shukla; Howard B Cottam; Michael Chan; Anthony J Molina; Maripat Corr; Tomoko Hayashi; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

4.  Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activation.

Authors:  Nikunj M Shukla; Michael Chan; Fitzgerald S Lao; Paul J Chu; Masiel Belsuzarri; Shiyin Yao; Jason Nan; Fumi Sato-Kaneko; Tetsuya Saito; Tomoko Hayashi; Maripat Corr; Dennis A Carson; Howard B Cottam
Journal:  Bioorg Med Chem       Date:  2021-05-30       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.